Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Erin Fenske Williams"'
Autor:
Erin Fenske Williams, Rhonda Oilepo, Theodore W. Laetsch, Hans J. Hammers, Susan Partridge, Asal Rahimi, Patrice Griffith, Muhammad Shaalan Beg, Penny Currykosky, Timothy J. Brown
Publikováno v:
JCO Oncology Practice. 16:e324-e332
PURPOSE: The time it takes a performing site to activate a clinical trial can directly affect the ability to provide innovative and state-of-the-art care to patients. We sought to understand the process of activating an oncology clinical trial at a m
Publikováno v:
Journal of Clinical Oncology. 40:60-60
60 Background: Advanced Practice Providers (APPs) represent a growing and increasingly important component of the oncology workforce. However, APP roles in clinical research are not clearly understood, and certain policies may limit participation. Fo
Autor:
Aaron B. Cohen, Melissa Estevez, Blythe J.S. Adamson, Erin Fenske Williams, Cary P. Gross, Amy J. Davidoff, Kelly Magee, Neal J. Meropol
Publikováno v:
The American journal of managed care. 27(7)
OBJECTIVES Racial disparities in cancer care and outcomes remain a societal challenge. Medicaid expansion through the Affordable Care Act was intended to improve health care access and equity. This study aimed to assess whether state Medicaid expansi
Autor:
Moon S. Chen, Ify Sargeant, Marianne Gandee, Nicole Richie, Julie H.T. Dang, Christopher Reddick, J'Aimee A. Louis, Homer Adams, Jovonni Spinner, Kenneth Turner, Rayneisha Watson, Quita Highsmith, Coleman K. Obasaju, Madeline Geday, Evelyn Gonzalez, Lola Fashoyin-Aje, Spencer C. Hoover, Jeanne M. Regnante, Simon J. Craddock Lee, Laura Lee Hall, Erin Fenske Williams
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 17, Iss, Pp-(2020)
Contemporary Clinical Trials Communications, Vol 17, Iss, Pp-(2020)
Background: Study populations in clinical research must reflect US changing demographics, especially with the rise of precision medicine. However, racial and ethnic minority groups (REMGs) have low rates of participation in cancer clinical trials. Me
Autor:
Erin Fenske Williams, Mary Stober Murray, Victoria Rollins, Anupama Santhosh, Jeanne Regnante
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:PO-105
Background: Diverse enrollment in clinical trials is a challenge for study sponsors, sites and patients. Non-Caucasians are underrepresented in cancer clinical trials relative to the burden of cancer they experience (1). Clinical trial participation
Autor:
Hans J. Hammers, Patrice Griffith, Asal Rahimi, Rhonda Oilepo, Theodore W. Laetsch, Muhammad Shaalan Beg, Penny Currykosky, Susan Partridge, Timothy J. Brown, Pamela Kurian, Erin Fenske Williams
Publikováno v:
Journal of Clinical Oncology. 37:296-296
296 Background: Initiating a new clinical trial is burdensome and complex. The time to activate a clinical trial can directly affect the ability to provide innovative, state-of-the-art care to patients. We sought to understand the process of activati
Autor:
Aaron B. Cohen, Amy J. Davidoff, Blythe J.S. Adamson, Erin Fenske Williams, Kelly Magee, Neal J. Meropol, Melissa Estevez, Cary P. Gross
Publikováno v:
Journal of Clinical Oncology. 37:LBA1-LBA1
LBA1 Background: Racial disparities in cancer outcomes remain a societal challenge. The ACA sought to improve equity in healthcare access and outcomes by permitting states to expand Medicaid and providing subsidies for purchase of private insurance.
Autor:
Jatan Clark, James B. Lorens, Rolf A. Brekken, Julia Schoelermann, Erin Fenske Williams, Andrew M. Lowy, Gayle S. Jameson, Muhammad Shaalan Beg, Hitendra Patel, Clare Massey, Kimberli Crane, Erkut Borazanci, Peter J. O'Dwyer, Daniel D. Von Hoff, Farjana J. Fattah
Publikováno v:
Journal of Clinical Oncology. 37:TPS473-TPS473
TPS473 Background: The Axl pathway coordinately mediates immune evasion and drug resistance in pancreatic cancer. Systemic Axl inhibition can enhance the efficacy of cancer therapy by blocking tumor cell proliferation, survival and drug resistance as
Autor:
Lola Fashoyin-Aje, Quita Highsmith, Coleman K. Obasaju, Michelle Vichnin, Simon J. Craddock Lee, Marvella E. Ford, Nicole Richie, Julie H.T. Dang, Luther T. Clark, Spencer C. Hoover, Evelyn Gonzalez, Jeanne M. Regnante, Nestor F. Esnaola, Gail Larkins, Erin Fenske Williams, J'Aimee A. Louis, Laura Lee Hall, Daniel G. Petereit, Lorna H. McNeill
Publikováno v:
Journal of Clinical Oncology. 36:e18643-e18643
e18643Background: By 2050, racial and ethnic minorities (REMs) will constitute > 50% of the US population. Despite a high prevalence of certain cancers in REM populations, < 10% REMs diagnosed with...
Autor:
Erin Fenske Williams, Tobi Duncan, Torsten Reimer, Simon J. Craddock Lee, Mary Gill, David E. Gerber, Sandra Garcia
Publikováno v:
Journal of Clinical Oncology. 35:e18215-e18215
e18215 Background: As evidenced by the NCI-ASCO Teams in Cancer Care Delivery initiative, there is growing interest in applying an emerging science of teams to oncology clinical care. Treatment of patients on cancer clinical trials requires coordinat